Breeze Medical
Breeze Medical
High-precision vacuum blood collection and centrifuge solutions
In the modern clinical diagnostic landscape, the Serum Separator Tube (SST) has become an indispensable component of the In-Vitro Diagnostics (IVD) industry. As global healthcare systems transition toward high-throughput automated laboratory systems, the demand for high-quality SSTs—featuring inert thixotropic gel and micronized silica clot activators—has surged.
Globally, the market is driven by the increasing prevalence of chronic diseases and the subsequent need for frequent blood analysis. From North American medical centers to emerging clinics in Southeast Asia, the efficiency of serum separation directly impacts the accuracy of biochemistry, immunology, and serology testing. China, as a leading manufacturing hub, now provides over 40% of the world's supply, combining technological innovation with economies of scale.
The shift toward "Total Lab Automation" requires SSTs to have perfect dimensions, vacuum stability, and gel integrity to prevent interference with sophisticated diagnostic probes.
Our SSTs utilize medical-grade PET or Glass with precision-sprayed Clot Activator (silica particles) to accelerate coagulation within 5-10 minutes, significantly reducing turnaround time (TAT).
We use proprietary thixotropic gel that forms a solid barrier between serum and blood cells during centrifugation, ensuring zero biochemical exchange for up to 48 hours.
Each tube undergoes rigorous vacuum retention testing. The safety caps are color-coded (Yellow/Gold) and designed to prevent aerosol leakage, protecting lab personnel.
The industry is currently witnessing three major shifts that every procurement officer and lab director should monitor:
For B2B buyers—ranging from national health services in Europe to private diagnostic chains in the Middle East—sourcing directly from certified China factories offers the best balance of quality-to-cost. Our logistics network ensures that temperature-sensitive gel remains stable during long-haul maritime or air freight.
Years Experience
Monthly Output
Export Countries
GMP Compliance
Our Authority in Medical Device Manufacturing
Ningbo Breeze Medical Co., Ltd., founded in 2011, has established itself as a leader in the medical device industry, specializing in the manufacturing of disposable medical consumables and laboratory instruments. Committed to providing the highest quality products, the company has invested in state-of-the-art infrastructure, including a cleanroom, an automatic injection molding workshop, and a support production line that meets the strictest GMP (Good Manufacturing Practice) standards. In addition, the company has set up a Product Quality Testing Center to ensure the reliability and performance of all its products.
Scientific research is a key pillar of Breeze Medical’s innovation. The company continuously invests in developing new technologies and products that contribute to improved healthcare.
We hold ISO 9001:2008, ISO 13485:2003, and CE marks. These are not just badges; they represent our promise of safety and efficacy to every patient and doctor.
Our team of highly skilled technical support engineers provides 24/7 assistance to address any customer inquiries, ensuring professional and timely service at all times.
The company has developed a cutting-edge processing capacity that allows it to manufacture products in large volumes without compromising on quality. Its modern production infrastructure includes advanced equipment that optimizes efficiency and precision in the manufacturing process. Key machinery includes:
Our Serum Separator Tubes are engineered for diverse environments:
By understanding the unique challenges of different regions—from the humidity of tropical clinics to the ultra-cold requirements of Northern European biobanks—we tailor our SST formulations for maximum stability.
 <p>Beyond the basics, the serum separator tube market is also evolving with the integration of <strong>Smart Labeling (RFID)</strong>. Ningbo Breeze Medical is at the forefront of exploring how siliconization and nanotechnology can further reduce non-specific binding of proteins to the tube walls, a critical factor for sensitive drug monitoring and proteomic research.</p>
</div>
</div>
</div>
</div>
<!-- Bottom Product Showcase (8 Items) -->
<div class=)
Bulk pricing available for international distributors
Ningbo Breeze Medical Co., Ltd. continues to move forward with a strong focus on quality, innovation, and global expansion, offering effective and reliable solutions for the medical and laboratory sectors.
